Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Aditya P. Lal"'
Autor:
Gabriel M Aisenberg, Moez Karim Aziz, Rosa M. Estrada-Y-Martin, Sungita Kumar, Maurine Sam, Sujith V. Cherian, Michael Burke, Amrutha Immadi, Tyler Webster, Brittany A. Kirsch, Aditya P. Lal
Publikováno v:
The American Journal of Medicine
Background: Deep vein thromboses (DVT) and pulmonary embolism (PE) are recognized complications of Coronavirus Disease 2019 (COVID-19). Currently, the need for Computed Tomography Pulmonary Angiogram (CTPA) relies on the Wells score together with ser
Autor:
Chang Li, Rosa M. Estrada-Y-Martin, Gabriel M Aisenberg, Stephan A Reyes, Sujith V. Cherian, Brad Roche, Aditya P. Lal
Publikováno v:
TP48. TP048 COVID: ARDS CLINICAL STUDIES.
Rationale Awake proning has been described as an effective intervention to improve oxygenation in nonintubated patients with acute hypoxemic respiratory failure secondary to coronavirus disease 2019 (COVID-19). However, it remains unclear whether awa
Autor:
Brad Roche, Siddharth Karanth, Gabriel M Aisenberg, Rosa M. Estrada-Y-Martin, Sujith V. Cherian, Stephan A Reyes, Chang Li, Aditya P. Lal
Publikováno v:
Respiratory Medicine
Background Awake prone positioning has been recommended as an adjunctive measure in spontaneously breathing patients with hypoxemic respiratory failure during the COVID-19 pandemic. It remains uncertain as to how long this should be implemented, what
Autor:
Daniel Ocasionez, Rosa M. Estrada Y Martin, Stephan A Reyes, Brad Roche, Sujith V. Cherian, Aditya P Lal, Farah Kazzaz
Publikováno v:
The American Journal of the Medical Sciences
COVID- 19 has become a major pandemic affecting more than 11 million people worldwide. Common radiological manifestations of COVID-19 include peripheral based ground-glass or consolidative opacities; however, pneumothorax and pneumo-mediastinum are v
Publikováno v:
International Journal of Stroke. 10:882-886
Objective To determine factors associated with patients refusing IV t-PA for suspected acute ischemic stroke (AIS), and to compare the outcomes of patients who refused t-PA (RT) with those treated with t-PA. Methods Patients who were treated with and
Publikováno v:
Stem Cells and Development. 21:1007-1015
Cell therapy is a novel investigational approach to enhance stroke recovery. Intra-arterial (IA) delivery has the potential advantage of selectively targeting cell therapies to the ischemic brain tissue. Over the past 10 years, IA cell delivery has b
Publikováno v:
Cell-Based Therapies in Stroke ISBN: 9783709111741
Stroke is the leading cause of disability and there are no proven therapies beyond the acute stage. Based on extensive animal data, there is mounting evidence that various types of cell therapies enhance recovery after stroke. We review intravenous d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b01552a938b38abc42002cc37b64ebc3
https://doi.org/10.1007/978-3-7091-1175-8_12
https://doi.org/10.1007/978-3-7091-1175-8_12
Autor:
Preeti sahota, Peter Sedrak, Paul S Lee, Aditya P Lal, William J Hicks, Navdeep Sangha, Tzu-Ching Wu, Farhaan Vahidy, James C Grotta, Sean I Savitz
Publikováno v:
Stroke. 43
Background: Moyamoya (MM) is a rare progressive arteriopathy characterized by progressive stenosis and occlusion of the internal carotid arteries (ICA) and ultimately the arteries of the circle of Willis. It is called moyamoya disease (MMD) when idio
Autor:
Preeti sahota, Farhaan Vahidy, James P Hovis, William J Hicks, Tzu-Ching Wu, Aditya P Lal, Zhongxue Chen, Rahbar M Hossein, James C Grotta, Sean I Savitz
Publikováno v:
Stroke. 43
Objective: Stringent selection criteria pose challenges to recruiting patients into clinical trials testing potential novel therapies for stroke. We conducted a pilot study, Safety of Intravenous Mononuclear Cells for Acute Stroke (SIMVAS) trial invo